scispace - formally typeset
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

D.M. Harnois
- 01 Jan 2010 - 
- Vol. 2010, pp 233-234
About
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.

read more

Citations
More filters
Journal ArticleDOI

Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment.

TL;DR: An enhanced screening policy combined with broader access to DAAs can diminish the future clinical and economic burden of HCV in the Lebanese population and, for the middle-aged and elderly, provide the greatest health benefit with net cost savings.

The bystander effect in hepatitis C virus infection: cellular interactions between infected cells and uninfected cells

TL;DR: This paper presents a meta-analyses of the immune system’s response to chemotherapy and shows clear patterns of decline in men and women aged between the ages of 40 and 74.
Journal ArticleDOI

Mortality and hospitalization for liver disease in the Western Amazon from 2008 to 2017

TL;DR: There is a tendency towards stability in cases of mortality and hospitalization due to liver diseases in the Western Amazonia, and male patients have the highest number of hospitalizations and are not different from mortality.
Journal ArticleDOI

Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.

TL;DR: The results demonstrate the feasibility of donor age restriction for LT recipients with HCV, and such information may be relevant to programs with limited access to new antiviral therapies for which modifying the risk of severe disease remains of paramount importance.
References
More filters
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)